ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Myeloma treatment and prognosis
Cost-benefit analysis of new cancer medicines: The difficult choices of governments
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
OncoAlert Round Up for September 22-28, 2023
Early-stage breast cancer detection in breast milk
OncoAlert Round Up for September 15-21, 2023
Osimertinib plus chemotherapy shows superior results versus osimertinib alone for EGFR-mutated advanced lung cancer
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
A reproducibility study in pulmonary adenocarcinomas supports a revised classification